Monthly Archives: February 2007

Investor Tool

Posted on February 19, 2007 by Mark Senak

Today is President’s Day – a holiday for many, especially here in the Beltway where the Federal government will be closed, though the only way we will notice is the light traffic on the commute this morning… In light of … Continue reading →

Posted in Miscellaney | Comments Off on Investor Tool

Weekly Roundup – 2/16/07

Posted on February 16, 2007 by Mark Senak

I am traveling outside the Beltway and having to meet real people (so you know I’m not in L.A!).  It is a nice change, though I have to say, the nation is frigid!  It was -3 degrees when I got … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 2/16/07

Perspective on FDA Image – Missing Opportunities

Posted on February 14, 2007 by Mark Senak

On December 11, following the vote to make Dr. Andrew C. von Eschenbach the FDA Commissioner, after years of "acting" status commissioners, I wrote in a posting:  "…Dr. von Eschenbach should use the opportunity of the next few months to … Continue reading →

Posted in FDA Image | Comments Off on Perspective on FDA Image – Missing Opportunities

Ketek Gets New Label

Posted on February 13, 2007 by Mark Senak

The FDA announced the issuance of a new label for Ketek (telithromycin) that strips away two indications for use of the drug – acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis – and retaining the sole remaining indication, … Continue reading →

Posted in Risk Management | Comments Off on Ketek Gets New Label

An Interview with Dr. von Eschenbach

Posted on February 12, 2007 by Mark Senak

The Sunday New York Times Magazine carried an interview with FDA’s Commissioner,  Dr. Andrew C. von Eschenbach that was noteworthy simply for the fact that the questions were more interesting than the answers.  The questions, in some respects, said a … Continue reading →

Posted in FDA Image | Comments Off on An Interview with Dr. von Eschenbach